Answers are grounded in this paper and cite their sources.
In this study, we describe the characterization of an infrequently encountered class A carbapenemase, IMI-1, from a clinical Enterobacter cloacae isolate. The isolate had high levels of resistance to carbapenems but retained susceptibility to expanded-spectrum cephalosporins. The blaIMI-1 gene was chromosomally encoded. Detection of the IMI-1 producer highlights the diversity of carbapenemases in a local clinical setting.
No takes yet. Share an insight, caveat, or question.
Teo et al. (2013) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: